Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $490,088 | $164 | $204 | $260 |
| - Cash | $22 | $0 | $2 | $2 |
| + Debt | $2 | $0 | $0 | $0 |
| Enterprise Value | $490,068 | $164 | $203 | $258 |
| Revenue | $3 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $2 | $0 | $0 | $0 |
| % Margin | 92.3% | – | – | – |
| EBITDA | -$64 | -$3 | -$0 | -$0 |
| % Margin | -2,437.5% | – | – | – |
| Net Income | -$61 | -$2 | -$0 | -$0 |
| % Margin | -2,313.3% | – | – | – |
| EPS Diluted | -1.66 | -0.15 | -0.018 | -0.009 |
| % Growth | -1,006.7% | -738% | -108.1% | – |
| Operating Cash Flow | -$51 | -$2 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$51 | -$2 | -$0 | -$0 |